BIO honors Senator Robert Menendez as Legislator of the Year.
Share:
Press Release Summary:
BIO has selected Senator Robert Menendez (D-NJ) as Legislator of the Year for 2009-2010. Senator Menendez received award as part of BIO Legislative Day Fly-In, which included discussions on patent reform, NIH/FDA funding, drug importation risks, and expanded eligibility for Small Business Innovation Research grants. While on Finance Committee, he has addressed Therapeutic Discovery Project Tax Credit and other issues critical to biotechnology community, said Jim Greenwood.
Original Press Release:
Senator Menendez Honored as BIO Legislator of the Year
WASHINGTON, D.C. - The Biotechnology Industry Organization (BIO) announced today its selection of Senator Robert Menendez (D-NJ) as Legislator of the Year for 2009-2010. Senator Menendez received the award as part of the BIO Legislative Day Fly-In earlier this week.
"During Senator Menendez's influential service on the Finance Committee, he has been a thoughtful and responsive champion of issues critical to the biotechnology community such as the Therapeutic Discovery Project Tax Credit. His leadership will help countless patients access advanced medical treatments, reduce long-term health costs in the United States, and help advance the goal of curing cancer," BIO President and CEO Jim Greenwood stated.
"Through his many years of service at the local, state and federal levels, Senator Menendez has understood the issues facing New Jersey and the nation. The great majority of the more than 250 biotech companies operating in New Jersey will be eligible to apply for the research credit, which in effect supports $1 billion in research directed at some of the nation's most pressing medical issues. Long term, it will benefit patients and their families and ensure the continuance of many of our small companies in New Jersey and beyond," said Debbie Hart, President of BioNJ.
More than 200 biotechnology industry representatives from 32 states will participate in hundreds of meetings with Members of the House and Senate during the BIO Legislative Day Fly-In. Participants will discuss issues critical to the biotechnology industry including patent reform, NIH/ FDA funding, drug importation risks, and expanded eligibility for Small Business Innovation Research grants.
Upcoming BIO Events
BIO Intellectual Property Counsels Spring Conference and Committee Meeting
April 19-21, 2010
New Orleans, LA
Partnering for Global Health
May 3, 2010
Chicago, IL
McCormick Place Convention Center
BIO International Convention
May 3-6, 2010
Chicago, IL
McCormick Place Convention Center
2010 BIO Human Resources Conference
May 4-7, 2010
Chicago, IL
World Congress on Industrial Biotechnology and Bioprocessing
June 27-30, 2010
Washington, DC
BIO India
September 21 - 22, 2010
Hyderabad, India
BIO's Livestock Biotechnology Summit
September 28-30, 2010,
Sioux Falls, SD
About BIO
BIO represents more than 1,200 biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and in more than 30 other nations. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology products. BIO also produces the BIO International Convention, the world's largest gathering of the biotechnology industry, along with industry-leading investor and partnering meetings held around the world.
